Article metrics
PDF
Other content recommended for you
- Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP
- Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features
- Application of the 2021 EAN/PNS criteria for chronic inflammatory demyelinating polyneuropathy
- Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment
- Treatment of CIDP
- Different electrophysiological profiles and treatment response in ‘typical’ and ‘atypical’ chronic inflammatory demyelinating polyneuropathy
- Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin
- Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study
- Anti-MAG/SGPG associated neuropathy does not commonly cause distal nerve temporal dispersion
- Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases